Ryan Preblick

Director of Finance/CFO chez INDIVIOR PLC

Fortune : 1 M $ au 31/03/2024

Health Technology

Consumer Services

Postes actifs de Ryan Preblick

Sociétés	Poste	Début	Fin
INDIVIOR PLC	Director of Finance/CFO	29/06/2020	-
	Director/Board Member	20/11/2020	-
	Comptroller/Controller/Auditor	01/01/2012	01/01/2020
	Corporate Officer/Principal	01/01/2020	29/06/2020
OPIANT PHARMACEUTICALS, INC.	Director of Finance/CFO	-	-
	Corporate Secretary	-	-
	Treasurer	-	-

The Pennsylvania State University	Undergraduate Degree
University of Richmond	Masters Business Admin

Internationale

Etats-Unis

Opérationnelle

Director of Finance/CFO	2
Comptroller/Controller/Auditor	1
Director/Board Member	1

Sectorielle

Health Technology	3
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
INDIVIOR PLC	Health Technology

Entreprise privées	1
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA.	Health Technology

Entreprise privées

Health Technology